DOCSLIB.ORG

Summer-Sept 2018 NUCLEUS 8-14-18Web

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Summer-Sept 2018 NUCLEUS 8-14-18Web Boston National Meeting Issue http://www.nesacs.org Summer/September 2018 Vol. XCVII, No.1 Monthly Meeting James Edward Phillips Sam Kean, Science Writer, to Speak at Salem State 1946-2018 University nd Life as an Assistant 22 Andrew H. Professor: A Weinberg Memorial Retrospective Lecture Nada Jabado, M.D., Ph.D. to Speak at Dana-Farber By Mindy Levine, 2018 NESACS Chair Cancer Institute James Edward Phillips January 9, 1946–June 13, 2018 house in Natick and we always enjoyed ford, Massachusetts until his retirement. his hospitality. James is survived by his devoted Jim was proud of his children and wife, Dr. Dorothy Wingfield Phillips of grandchildren and often talked of his vis- Natick. He was a loving dad to Vickie its to Georgia to visit his son, Anthony, A. Thomas and her husband Albert of and daughter, Vickie, and their families. Ellenwood, GA; Pastor Anthony J. I remember teasing him as to whether Phillips of Atlanta, GA and Crystal J. there was any family conflict when the Mayo of Natick. He was the grandfather Patriots played the Falcons in Super of Braelen Phillips; Andrew Phillips; Bowl LI. Another daughter, Crystal, Anthony Phillips, Jr; Elizabeth Mayo; lives locally with her children. Logan Mayo; Brian Walker and Eric James Phillips was born on January Lockett and Great-grandfather of Brian 9, 1946 in Nashville, TN to the late Mar- Walker, Jr. We are sorry to report the passing of garet E. (Phillips) Walker and Douglas He was the brother of Herbert James Edward Phillips. James was a Harris. He received his B.S. degree from Phillips and his wife Cassaundra; Dou- longtime contributor to NESACS and Tennessee State University in Nashville glas Harris, Jr.; Riley Harris; Deborah husband of ACS Board of Directors and his M.S. in Inorganic Chemistry Harris and Mitzi Harris, all of Nashville, Member, Dorothy Phillips. James was a from the University of Cincinnati. Tennesee. He was brother-in-law of Dr. long-time member of the Board of Pub- Jim was a Research Chemist at Robert Wingfield; Oddie Wingfield and lications (BOP) including several terms Sheppard Chemical Company, Norwood, Dr. Shirley Wingfield; Dwight Wing- as chair. He had a passion for photogra- Ohio; a Technical Service Engineer at field; Addie Jenkins; Patricia McCarroll; phy and contributed many photos to the the Dow Chemical Company, Midland, Elsie Hurt, all of Nashville, TN and Rev. Nucleus and the NESACS website. He Michigan; Chemical Supervisor at Margaret Smith of Belleville, IL. James served NESACS as a Director-at-Large Corning Medical, Medfield, Massachu- was preceded in death by his sister and he ran for Chair of NESACS in 2013. setts; Laboratory Supervisor at Muro Paulette Gray and his nurturing uncle The members of the BOP received Pharmaceutical Company, Tewksbury, and aunt George and Ethel Hart. an ominous email on June 12 that Jim Massachusetts and a Technical Service u -M. Filosa had a heart attack. He passed the next Engineer at Waters Corporation, Mil- day and the membership was notified broadly on June 15. His wake was held the following Tuesday in Wayland at the John C. Bryant Funeral Home. His serv- ice was held the next morning at the Fisk United Methodist Church in Natick and interment followed immediately after at the Dell Park Cemetery in Nat- ick. Family kindly suggests that memo- rial gifts in James’ memory be sent to Fisk United Methodist Church, 106 Walnut St, Natick, MA 01760 or The Multiple Myeloma Research Fund, 383 Main Avenue, 5th Floor, Norwalk, CT 06851. For condolences please visit: www.johncbryantfuneralhome.com I don’t remember when I first met Jim, but I recall him first as a photogra- pher for the Nucleus when I became ed- itor in 2005. He was always a most congenial person and I always enjoyed seeing him whether it was at a National Meeting of the American Chemical So- ciety or one of our local section meet- ings. He graciously hosted several Board of Publications meetings at his 2 The Nucleus Summer/September 2018 The Northeastern Section of the American- Chemical Society, Inc. Contents Office: Anna Singer, 12 Corcoran Road, Burlington, MA 01803 James Edward Phillips 2 (Voice or FAX) (781)272-1966. ___________________________________ e-mail: [email protected] NESACS Homepage: January 9, 1946-June 13, 2018 http://www.NESACS.org Life as an Assistant Professor: A Retrospective 4 Officers 2018 ______________ Chair By Mindy Levine Mindy Levine 35 Cottage St Monthly Meeting 5 Sharon, MA 02067-2130 _______________________________________ (516)697-9688 Sam Kean, Science Writer, to Speak at Salem State University [email protected] Report on the 21st Andrew H. Weinberg Memorial Lecture 6 Chair-Elect Andrew Scholte ______ Sanofi By Robert Levy, Dana-Farber Cancer Institute Waltham, MA The 22nd Annual Andrew H. Weinberg Lecture 7 617-459-5145 _______________ [email protected] Nada Jabado, M.D., Ph.D. to speak at Dana-Farber Cancer Institute Immediate Past Chair Leland L. Johnson, Jr. Call for Nominations 8 Euretos ____________________________________ Cambridge, MA 2018 Theodore William Richards Medal Award, The Gustavus John Esselen +1.617.304.6474 [email protected] Award for Chemistry in the Public Interest, NSYCC/NESACS-JCF/GDCh Ex- Secretary change to Germany, March 2019. Michael Singer A Medicinal Chemistry Symposium 9 MilliporeSigma _________________________ 3 Strathmore Rd, Natick, MA 01760 (774)290-1391, [email protected] “The Future of Anti-infectives” Treasurer 2018 NESACS Election Results 9 Ashis Saha ___________________________ 67 Bow St Chemical Biology in the Hub Announcement 10 Arlington, MA 02474-2744 (978)212-5462 ________________ [email protected] 2018 NESACS Process Chemistry Symposium Announcement 11 Auditor __ Patrick Gordon Esselen Award Photos by Joel Laino 12 Archivist _______________________ Ken Mattes Cover: Trustees Dr. James Bradner, M.D., President, Novartis Institutes for Biomedical Peter C. Meltzer, Dorothy Phillips, Ruth Tanner Research, speaks at the 21st Annual Andrew H. Weinberg Memorial Lecture on Directors-at-Large David Harris, June Lum, Michael P. Filosa, “New Paths to the Waterfall: Rethinking the Science of Therapeutics for Pedi- John Neumeyer, James U. Piper, Ralph Scannell atric Malignancies.” (Photo by Sam Ogden) Councilors/Alternate Councilors Editorial Deadlines: Term Ends 12/31/2018 November 2018 Issue: September 15, 2018 Katherine Lee Chris Moreton December 2018 Issue: October 15, 2018 Catherine E. Costello Ajay Purohit Ruth Tanner June Lum Kenneth Mattes Malika Jeffries-EL Jackie O’Neil Joshua Sacher Term Ends 12/31/2019 Thomas R. Gilbert Ashis Saha Mary Jane Shultz Mary A. Mahaney Michael Singer Jerry P. Jasinski Lisa Marcaurelle Raj (SB) Rajur The Nucleus is published monthly, except June and August, by the Northeastern Section of the American Leland L. Johnson, Jr. Matthew M. Jacobsen Chemical Society, Inc. Forms close for advertising on the 1st of the month of the preceding issue. Text Term Ends 12/31/2020 must be received by the editor six weeks before the date of issue. Michael P. Filosa Morton Z. Hoffman Editor: Michael P. Filosa, Ph.D., 18 Tamarack Road, Medfield, MA 02052 Email: Carol Mulrooney Sonja Strah-Pleynet Patricia A. Mabrouk Andrew Scholtet [email protected]; Tel: 508-843-9070 Anna W. Sromek Patrick M. Gordon Associate Editors: Myron S. Simon, 60 Seminary Ave. apt 272, Auburndale, MA 02466 Sofia A. Santos Morton Z. Hoffman, 23 Williams Rd., Norton, MA 02766 Board of Publications: Ajay Purohit (Chair), Mary Mahaney, Ken Drew, Katherine Lee All Chairs of standing Business Manager: Vacant: contact Michael Filosa at [email protected] Committees, the editor of THE NUCLEUS, and Advertising Manager: Vacant: contact Michael Filosa at [email protected] the Trustees of Section Calendar Coordinator: Vacant: contact Michael Filosa at [email protected] Funds are members of the Photographers: Morton Hoffman Board of Directors. Any Coun cilor of the American Chemical Society Proofreaders: Donald O. Rickter, Morton Z. Hoffman residing within the section area is an ex officio Webmaster: Roy Hagen, Email: [email protected] member of the Board of Directors. Copyright 2018, Northeastern Section of the American Chemical Society, Inc. The Nucleus Summer/September 2018 3 Life As An Assistant NESACS Sponsors 2017 Platinum $5000+ Professor: Boston Foundation Esselen Award SK Life Science A Retrospective Amgen, Inc Johnson Matthey Mindy Levine, Associate Chemistry Professor Vertex Pharmaceuticals 2018 Chair, Northeastern Section of the American Chemical Society Davos Pharma Biogen I remember when I thought that getting working around the clock to prepare and tenure was going to be my ticket to less deliver my advanced organic chemistry PCI Synthesis work, that the days, nights, and week- course for senior-level graduate students Navin Fluorine International Ltd ends of seemingly endless work to ob- for the first time. Mostly I kept teaching Gold $3000 up to $5000 tain tenure was going to come to an end that same class, although there was one Merck Research Corp at some point in the not-so-distant fu- semester where I taught 192 sopho- Signal Pharmaceuticals ture. It was that hope, partially, that nur- more-level students who were majoring J-Star Research tured me through six years of Assistant in biology, engineering, pharmaceutical IPG Women Chemists Professorship, from 2010 to 2016. That sciences, nursing, animal sciences, and Abbvie light at the end of the tunnel of getting a seemingly endless array of other major tenure would make it all worth it, I fig- fields of study, none of which were Silver $1500 up to $3000 ured, and soon that day would come. chemistry. “You don’t understand,” one Mettler Toledo Being an Assistant Professor was student wrote on a mid-semester evalu- Sanofi US Services interesting, to say the least. During those ation, which I distributed in order to pro- Warp Drive Bio six years of my life, I applied for more vide students with the opportunity to Pfizer than 100 grants.
Load more

Recommended publications
  • Pomona College Magazine Fall/Winter 2020: the New (Ab
    INSIDE:THE NEW COLLEGE MAGAZINE (AB)NORMAL • The Economy • Childcare • City Life • Dating • Education • Movies • Elections Fall-Winter 2020 • Etiquette • Food • Housing •Religion • Sports • Tourism • Transportation • Work & more Nobel Laureate Jennifer Doudna ’85 HOMEPAGE Together in Cyberspace With the College closed for the fall semester and all instruction temporarily online, Pomona faculty have relied on a range of technologies to teach their classes and build community among their students. At top left, Chemistry Professor Jane Liu conducts a Zoom class in Biochemistry from her office in Seaver North. At bottom left, Theatre Professor Giovanni Molina Ortega accompanies students in his Musical Theatre class from a piano in Seaver Theatre. At far right, German Professor Hans Rindesbacher puts a group of beginning German students through their paces from his office in Mason Hall. —Photos by Jeff Hing STRAY THOUGHTS COLLEGE MAGAZINE Pomona Jennifer Doudna ’85 FALL/WINTER 2020 • VOLUME 56, NO. 3 2020 Nobel Prize in Chemistry The New Abnormal EDITOR/DESIGNER Mark Wood ([email protected]) e’re shaped by the crises of our times—especially those that happen when ASSISTANT EDITOR The Prize Wwe’re young. Looking back on my parents’ lives with the relative wisdom of Robyn Norwood ([email protected]) Jennifer Doudna ’85 shares the 2020 age, I can see the currents that carried them, turning them into the people I knew. Nobel Prize in Chemistry for her work with They were both children of the Great Depression, and the marks of that experi- BOOK EDITOR the CRISPR-Cas9 molecular scissors. Sneha Abraham ([email protected]) ence were stamped into their psyches in ways that seem obvious to me now.
    [Show full text]
  • World's Leading Scientists and Technologists to Gather at the Global
    MEDIA RELEASE WORLD’S LEADING SCIENTISTS AND TECHNOLOGISTS TO GATHER AT THE GLOBAL YOUNG SCIENTISTS SUMMIT 2021 Summit will host 21 eminent scientists including Nobel Laureates, who will engage and share first-hand insights in science and research with over 500 young scientists from 30 countries 6 JANUARY 2021, SINGAPORE – The National Research Foundation Singapore (NRF) will host the ninth edition of the Global Young Scientists Summit (GYSS), which will see the gathering of the world’s foremost scientists and technologists engage and inspire aspiring young scientists. Held virtually from 12 to 15 January 2021, the eminent scientists will also discuss the latest advances in research and how they can be used to develop solutions to address major global challenges. The Summit will be graced by Singapore’s Deputy Prime Minister and Chairman of NRF, Mr Heng Swee Keat, who will deliver the opening address. The GYSS is a multi-disciplinary event covering the disciplines of chemistry, physics, biology, mathematics, computer science, and engineering. During the event, luminary scientists and technologists will share details of their discoveries by delivering plenary addresses, participating in panel discussions, and engaging with the young scientists in small group discussions. They will also provide mentorship to over 500 young researchers from more than 30 countries. Star-studded panel speaking on a wide range of subjects and issues This year, the GYSS sees 21 speakers, the highest number since the start of the Summit, of whom 17 are speaking at the Summit for the first time. The list includes Nobel Laureates, Fields Medallists, Millennium Technology Prize and the Turing Award winners.
    [Show full text]
  • Press Release Emmanuelle Charpentier and Jennifer Doudna
    Press Release Emmanuelle Charpentier and Jennifer Doudna to receive the 2016 HFSP Nakasone Award The Human Frontier Science Program Organization (HFSPO) has announced that the 2016 HFSP Nakasone Award has been awarded to Emmanuelle Charpentier of the Max Planck Institute for Infection Biology, Berlin, Germany and Umeå University, Sweden and Jennifer Doudna of the University of California at Berkeley, USA for their seminal work on gene editing by means of the CRISPR-Cas9 system. Emmanuelle Charpentier Jennifer Doudna The HFSP Nakasone Award was established to honor scientists who have made key breakthroughs in fields at the forefront of the life sciences. It recognizes the vision of Japan’s former Prime Minister Nakasone in the creation of the Human Frontier Science Program. Charpentier and Doudna will present the HFSP Nakasone Lecture at the 16th annual meeting of HFSP awardees to be held in Singapore, in July 2016. A discovery in the late 1980s revealed that neighboring bacterial DNA segments contain repeating nucleotide sequences which flank short segments. In 2007, it was shown that these repeating sequences, termed CRISPR (clustered regularly interspaced short palindromic repeats), are part of a bacterial defense system against foreign DNA. Through their recent joint study, initiated in 2011, Charpentier and Doudna have shown that the system can be harnessed as a genetic tool to efficiently and specifically edit DNA targeting any sequence in the genome. Emmanuelle Charpentier’s laboratory started to focus on the bacterial CRISPR-Cas9 system by investigating it in the human pathogen Streptococcus pyogenes. Her team described the three components of the system that consist of two RNAs forming a duplex (tracrRNA and crRNA) and the protein Cas9 (formerly named Csn1) and showed the roles of each component in the early steps of activation of the system (duplex RNA co-processing and in vivo phage sequence targeting).
    [Show full text]
  • PRESS RELEASE August 3, 2020 WINNER of CARL SAGAN PRIZE
    PRESS RELEASE August 3, 2020 WINNER OF CARL SAGAN PRIZE FOR SCIENCE POPULARIZATION ANNOUNCED SAN FRANCISCO — Wonderfest, the 23-year-old Bay Area Beacon of Science, announced today that neuroscientist Dr. Matthew Walker has won the 2020 Carl Sagan Prize for Science Popularization. Wonderfest’s Sagan Prize is presented specifically to recognize and encourage researchers who “have contributed mightily to the public understanding and appreciation of science.” Past Sagan Prize winners include UC Berkeley gene editor Jennifer Doudna, SETI Institute astronomer Jill Tarter, and Stanford Nobel Laureate Paul Berg. The prize includes a $5000 cash award. “Wonderfest was born in 1997, just a few months after the death of researcher and popularizer Carl Sagan,” notes the organization’s founding executive director, Tucker Hiatt. “Wonderfest’s work has been dedicated to Sagan’s memory ever since. Sagan would be proud to know that Matthew Walker, so renowned for his research and his outreach, has received Wonderfest’s Sagan Prize for 2020.” Wonderfest is a nonprofit corporation dedicated to informal science education and popularization, particularly among adults in the San Francisco Bay Area. When pandemic constraints allow, Wonderfest produces in-person science events — and their online videos — in an effort to “enlarge the concept of scientific community.” Wonderfest also produces “Science Envoy” workshops to develop the science communication skills of Bay Area PhD students. Walker is Professor of Neuroscience and Psychology at the University of California, Berkeley. He earned a degree in neuroscience from Nottingham University, UK, and a PhD in neurophysiology from the Medical Research Council, London, UK. He subsequently became a Professor of Psychiatry at Harvard Medical School.
    [Show full text]
  • Emmanuelle Charpentier
    8 “It’s really amazing how quickly PHOTO: DEREK HENTHORN FOR MPG; ILLUSTRATION: HENNING BRUER research into CRISPR-Cas9 and its possible applications has developed in recent years.” Max Planck Research · 3 | 2020 NOBEL PRIZE IN CHEMISTRY EMMANUELLE CHARPENTIER CRISPR-Cas9 as an adaptive im- also relatively straightforward in mune system that bacteria and ar- terms of its operation, it’s hard to chaea use to defend themselves imagine laboratory work without it CRISPR-Cas9 contains two molecules of RNA from attacks by viruses. In 2011, nowadays. However, CRISPR-Cas9 that can be combined Emmanuelle Charpentier and her has not only revolutionized basic into a single molecule. research groups, who were con- research, but has also become an A recognition sequence ducting joint research at Umeå indispensable tool in medicine, matching a specific University and the University of biotechnology, and agriculture. In- 9 sequence on the DNA Vienna at the time, described deed, physicians around the world strand directs the enzyme Cas9 to the location where tracrRNA – an RNA molecule that are working flat out to convert the it should cut the strand. activates the CRISPR-Cas9 CRISPR-Cas9 technology into system. A year later, Charpentier therapies for as-yet-untreatable and Doudna published their fin- diseases. Microorganisms with dings describing exactly how modified genetic material are in- CRISPR-Cas9 homes in on the tended to improve the efficiency of correct location in the DNA strand food and medicine production. With some discoveries, it seems like it and how the system can be used as And agricultural crops whose ge- will only be a matter of time before a tool for modifying genetic mate- netic material has been modified they are honored with the Nobel rial.
    [Show full text]
  • AMA Journal of Ethics® December 2019, Volume 21, Number 12: E1042-1048
    AMA Journal of Ethics® December 2019, Volume 21, Number 12: E1042-1048 HEALTH LAW What Is Prudent Governance of Human Genome Editing? Scott J. Schweikart, JD, MBE Abstract CRISPR technology has made questions about how best to regulate human genome editing immediately relevant. A sound and ethical governance structure for human genome editing is necessary, as the consequences of this new technology are far-reaching and profound. Because there are currently many risks associated with genome editing technology, the extent of which are unknown, regulatory prudence is ideal. When considering how best to create a prudent governance scheme, we can look to 2 guiding examples: the Asilomar conference of 1975 and the German Ethics Council guidelines for human germline intervention. Both models offer a path towards prudent regulation in the face of unknown and significant risks. Introduction In recent years, there has been a significant debate regarding human genome editing. The debate has intensified with the advent of CRISPR1,2 and the births of twin girls in China whose genomes were edited at the embryo stage using CRISPR technology.3 This new technology has certain risks of unknown magnitude coupled with potentially far- reaching consequences—ranging from safety and efficacy concerns, to more nuanced social and ethical implications, to globally profound implications, such as the shaping of human evolution. The potential risks and consequences of genome editing have raised concerns around the world. Debates are currently unfolding about how best to regulate this technology.4,5,6 Regulation can take many forms, which may include a moratorium on the technology’s use or assessment and enactment of restrictions and standards by regulatory agencies.
    [Show full text]
  • Jennifer A. Doudna Adam Grosvirt-Dramen Hochbaum Lab Group Meeting 10/22/2020
    Super scientist: Jennifer A. Doudna Adam Grosvirt-Dramen Hochbaum Lab Group Meeting 10/22/2020 https://www.emmanuelle-charpentier-lab.org/ Who is a scientist (living or dead) that you admire? In what field did they work? • Dr. Jennifer A. Doudna • Biochemistry professor at UC Berkeley working on gene editing using CRISPR technology • Chemistry Nobel Laureate 2020 Summarize their career history - where did they study, what fields, any non-academic pursuits? How did they get to the point in their career when they made significant impact on their field? B.A. Chemistry Ph.D. Biochemistry, 1989 Lucille P. Markey Scholar in Henry Ford II Professor of 1985 Post-Doc, 1989-1991 Biomedical Science, 1991-1994 Molecular Biophysics and Dr. Sharon Panasenko Dr. Jack W. Szostack Dr. Thomas R. Cech Biochemistry, 1994-2002 (Nobel 2009) (Nobel 1989) Professor of Biochemistry and Molecular Biology at UC Berkeley and Faculty Scientist at LBNL in the Physical Biosciences Division 2003-Present https://doudnalab.org/people/ Summarize their career history - where did they study, what fields, any non-academic pursuits? How did they get to the point in their career when they made significant impact on their field? COMMON RESEARCH THEME B.A. Chemistry Ph.D. Biochemistry, 1989 Lucille P. Markey Scholar in Henry Ford II Professor of 1985 Post-Doc, 1989-1991 Biomedical Science, 1991-1994 Molecular Biophysics and Dr. Sharon Panasenko Dr. Jack W. Szostack Dr. Thomas R. Cech (Nobel 1989) Biochemistry, 1994-2002 RNA CHEMISTRY Professor of Biochemistry and Molecular Biology
    [Show full text]
  • Hello, and Welcome to Research Matters Podcasts. Today, I
    Hello, and welcome to Research Matters Podcasts. Today, I, Aishwarya Viswamitra, welcome you to part one of our series on the research behind the Nobel prizes of the year 2020! In this episode, we discuss the Nobel Prize in Chemistry. The 2019 winners, Akira Yoshino, M Stanley Whittingham and John B Goodenough, won the Nobel Prize for the development of lithium-ion batteries. This year Emmanuelle Charpentier and Jennifer Doudna won the Nobel Prize for the development of a method of genome editing called CRISPR/cas9. <music> Our DNA — which makes each of us unique — is made up of subunits called genes. These genes have a variety of functions. It tells us our bodies how to create various proteins. It contains the recipe that tells your body how to develop. In fact, you are able to listen to this podcast because certain genes told your body to make up all the parts of your ears like the eardrum and the auditory nerve leading to the brain. But, sometimes, because of a mutation or a change in these genes, some people are born deaf. Now imagine a possibility to correct these mutations in the developing foetus and give the person the ability to hear. Well, this is no longer a far fetched fantasy, thanks to the Nobel Prize-winning technique for genome editing called CRISPR/cas9. The technique is based on a phenomenon that occurs within many species of bacteria. When a virus infects a bacterium, it injects its DNA into the bacterial cell. If the bacterium survives the infection, it inserts a piece of the viral DNA into its genetic data, carrying it around like a memory! Thus, a part of the bacterial genome is dedicated to viral DNA from all its past encounters, and in between each of these viral DNA segments is a peculiar sequence of DNA.
    [Show full text]
  • Wednesday Afternoon Lecture Series 2014–2015
    3:00 p.m. WEDNESDAY AFTERNOON Masur Auditorium LECTURE SERIES 2014–2015 Building 10 September 2014 October 2014 November 2014 SEPTEMBER 3, 2014 OCTOBER 1, 2014 OCTOBER 22, 2014 NOVEMBER 5, 2014 Florence Mahoney Lecture Andrew P. Feinberg Rakesh K. Jain Christopher Garcia The epigenetic basis of Eric Schadt Normalizing the tumor Tuning cytokine receptor common human disease A multiscale biology approach microenvironment to enhance signaling with natural and for dissecting the complex cancer treatment engineered ligands processes underlying aging and aging related phenotypes SEPTEMBER 10, 2014 NOVEMBER 12, 2014 OCTOBER 8, 2014 OCTOBER 29, 2014 Astute Clinician Lecture Megan A. Moreno George Khoury Lecture DeWitt Stetten, Jr., Lecture Using social media to Jay Hoofnagle investigate adolescent health Paul Bieniasz Ronald Vale Past and future therapy for Intrinsic host defenses The mechanisms of cytoskeletal hepatitis C against HIV-1 motor proteins SEPTEMBER 17, 2014 NOVEMBER 19, 2014 Leslie B. Vosshall Roy Bar-Ziv The neurogenetics of Programmable on-chip innate behaviors DNA compartments as “artificial cells” December 2014 January 2015 February 2015 March 2015 DECEMBER 3, 2014 JANUARY 7, 2015 FEBRUARY 4, 2015 MARCH 11, 2015 Robert S. Gordon Lecture G. Burroughs Mider Lecture NIH Director’s Lecture Margaret Pittman Lecture (first of three) Shiriki Kumanyika Crystal L. Mackall Jennifer Doudna Research directions for solving The immune system in Max Cooper The biology of CRISPRs: the obesity epidemic in high childhood cancer: Mobilizing Lecture Title TBD From genome defense to risk populations the troops Genomic engineering DECEMBER 10, 2014 JANUARY 14, 2015 FEBRUARY 11, 2015 MARCH 18, 2015 John Mekalanos NIH Director’s Lecture Titia de Lange Maiken Nedergaard (second of three) The extraordinary bacterial How telomeres solve the The nightlife of the brain Type VI secretion machine end-protection problem Richard Flavell Lecture Title TBD JANUARY 21, 2015 FEBRUARY 18, 2015 MARCH 25, 2015 Stuart H.
    [Show full text]
  • CRISPR As Agent: a Metaphor That Rhetorically Inhibits the Prospects for Responsible Research Leah Ceccarelli
    Ceccarelli Life Sciences, Society and Policy (2018) 14:24 https://doi.org/10.1186/s40504-018-0088-8 RESEARCH Open Access CRISPR as agent: a metaphor that rhetorically inhibits the prospects for responsible research Leah Ceccarelli Correspondence: [email protected] Department of Communication, Abstract University of Washington, Box Science 353740, Seattle, WA 98195-3740, In 2015, a group of 18 scientists and bioethicists published an editorial in USA calling for “open discourse on the use of CRISPR-Cas9 technology to manipulate the human genome” and recommending that steps be taken to strongly discourage “any attempts at germline genome modification” in humans with this powerful new technology. Press reports compared the essay to a letter written by Paul Berg and 10 other scientists in 1974, also published in Science, calling for a voluntary deferral of certain types of recombinant DNA experimentation. A rhetorical analysis of the metaphors in these two documents, and in the summary statements that came out of the respective National Academy of Sciences conferences they instigated, shows that while they have a lot in common, they are different in at least one important way. The more recent texts deploy conceptual metaphors that portray the biotechnology in question as an autonomous agent, subtly suggesting an inevitability to its development, in contrast to the earlier texts, which portray the scientists who are using the technology as the primary agents who take action. Rhetorical moves depicting biotechnology as an agent in the 2015 texts hint at contemporary skepticism about whether humans can restrain the forward momentum of science and technology in a global context, thus inhibiting scientists from imagining a consequential role for themselves in shaping the future of responsible research.
    [Show full text]
  • Prof. Emmanuelle Charpentier (France) Dr. Jennifer
    “Life Science” field of RNA, including the elucidation of the three-dimensional structure of ribozyme crystals. Achievement : Elucidation of the genome editing mechanism From 2002, she has worked as a professor at the University of by the CRISPR-Cas California, Berkeley. Since she became aware of the hypothesis about Prof. Emmanuelle Charpentier (France) CRISPR’s potential role in the adaptive immunity of bacteria around Born: December 11, 1968 (Age 48) 2005, she had been conducting research to elucidate the role of RNA Director, Max Planck Institute for Infection Biology (Berlin) in the defense mechanism of cells. Looking back, Dr. Doudna feels that upon meeting Prof. Charpentier, Dr. Jennifer A. Doudna (USA) intuition told her they could complement each other through joint Born: February 19, 1964 (Age 52) research. Thus began a long distance research collaboration bridging Professor, University of California, Berkeley Northern Europe and the West Coast of the United States, which soon produced results that would astonish the world. Summary Genome editing using the CRISPR-Cas system, announced by Prof. Emmanuelle Charpentier and Dr. Jennifer Doudna in 2012, is a The birth of a genome editing technology revolutionary new technology in genetic engineering. It was adopted that enables us to freely rewrite DNA at an explosive rate as a useful tool for research in the life sciences. Today, it continues to be applied to research in a wide range of fields, Already in June of the year following their first meeting, the joint such as breeding, drug development and medicine. This technology research group used the DNA of streptococcus pyogenes provided by was developed in the process of elucidating the bacterial defense Prof.
    [Show full text]
  • Japan Prize 2021
    dic196 2021 SINCE 1985 www.japanprize.jp ARK Mori Building, East Wing 35th Floor, 1-12-32 Akasaka, Minato-ku, Tokyo, 107-6035, JAPAN Tel: +81-3-5545-0551 Fax: +81-3-5545-0554 CONTENTS Significance of the JAPAN PRIZE -2- JAPAN PRIZE - Peace and prosperity for mankind -3- The Japan Prize Foundation -4- Directors, Auditors and Councilors of the Foundation Main Activities of the Foundation -6- THE JAPAN PRIZE -8- Nomination and Selection Process Fields Selection Committee and Selection Committee Eligible Fields for the 2022 Japan Prize Profiles of Japan Prize Laureates -11- Donating to our Foundation -49- Significance of the JAPAN PRIZE Chairman Yoshio Yazaki The peace and prosperity of mankind are the common Konosuke Matsushita, and many of the predecessors aspirations for people of the world. When looking back over involved in the creation of the prize still live on in Matsushi- the history of humanity, science and technology have played ta’s philosophy of “Lifelong Ambition”. an immense role in this cause. Every year in April, the Presentation Ceremony and The Japan Prize is an international award presented to Banquet are held in Tokyo in the presence of Their Majesties individuals whose original and outstanding achievements the Emperor and Empress of Japan, and are also attended by are not only scientifically impressive but have also served to prominent figures such as the Speaker of the House of Repre- promote peace and prosperity for all mankind. Since its sentatives, the President of House of Councilors, the Chief inception in 1985, the Foundation has awarded 101 laureates Justice of the Supreme Court, as well as other distinguished from 13 countries as of this year.
    [Show full text]